Source link : https://newshealth.biz/health-news/fda-approves-dupilumab-for-bullous-pemphigoid/
Dupilumab has been approved by the FDA for the treatment bullous pemphigoid in adults, the manufacturer Regeneron announced. Dupilumab (Dupixent), a human monoclonal antibody that inhibits interleukin (IL)-4 and IL-13 signaling, is now approved in the United States for eight diseases, including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. […]
The post FDA Approves Dupilumab for Bullous Pemphigoid first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-20 15:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8